ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
0.4177
+0.0017 (0.41%)
At close: Oct 30, 2025, 4:00 PM EDT
0.4260
+0.0083 (1.99%)
After-hours: Oct 30, 2025, 7:57 PM EDT
ProMIS Neurosciences Market Cap
ProMIS Neurosciences has a market cap or net worth of $22.48 million as of October 30, 2025. Its market cap has decreased by -26.22% in one year.
Market Cap
22.48M
Enterprise Value
17.93M
1-Year Change
-26.22%
Ranking
Category
Stock Price
$0.42
Market Cap Chart
Since April 16, 2012, ProMIS Neurosciences's market cap has increased from $21.82M to $22.48M, an increase of 3.00%. That is a compound annual growth rate of 0.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 22.48M | -27.45% |
| Dec 31, 2024 | 30.98M | 42.66% |
| Dec 29, 2023 | 21.72M | -41.67% |
| Dec 30, 2022 | 37.23M | -24.28% |
| Dec 31, 2021 | 49.17M | 104.73% |
| Dec 31, 2020 | 24.02M | -34.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.35B |
| Johnson & Johnson | 449.52B |
| AbbVie | 401.54B |
| UnitedHealth Group | 338.98B |
| AstraZeneca | 255.54B |
| Novartis AG | 250.89B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 220.41B |